Dezocine combined with sufentanil versus sufentanil for postoperative patient-controlled intravenous analgesia: a systematic review

Zhongyuan Xia,Shaoqun Tang,Juying Liu

DOI: https://doi.org/10.3760/cma.j.issn.1673-4378.2015.05.008

2015-01-01

Abstract:Objective To evaluate the clinical efficacy and adverse effect of a combination of and sufentanil versus sufentanil for postoperative patient-controlled intravenous analgesia (PCIA).Methods The relevant randomized controlled trials were searched in the Cochrane Library,PubMed,Embase,CBM,Ovid,ScienceDirect,ProQuest,Springer,CNKI,WanFang Data and VIP databases (updated to June 2014).The quality of the included studies was evaluated after data extraction according to the inclusion and exclusion criteria by two reviewers independently.The Meta-analysis was performed by using RevMan 5.1 software.Results Six trials with a total of 477 patients were included.The results showed that there were no significant differences of visual analog scale(VAS) at 4,8,12 h,and 24 h between groups(P＞0.05).However the VAS at 48 h was decreased in dezocine combined with sufentanil group[weighted mean difference(WMD)=-0.36,95％ confidence interval(CI) (-0.69,-0.04)] (P＜0.05).There were significant differences in adverse effects[odds ratio(OR)=0.36,95％CI (0.26,0.50)] (P＜0.05).There were significant differences of interleukin (IL)-6 and IL-10 at 24 h and 48 h postoperatively (P＜0.05).Conclusions Dezocine combined with sufentanil provide sufficient analgesia effect but with fewer adverse effects and seemed to improve the systematic immune function for postoperative patient-controlled intravenous analgesia.